glp 1 receptor agonist medicines GLP-1 Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Best Med #2: GLP-1 Receptor

Group mean metabolite concentrations were significantly lower in the patients than in the controls for both glutathione and glutamine in the ACC, and significantly lower for all three metabolites in the ACC in the subset of patients with residual schizophrenia

10.2337/dc08-1736 54 HathcockJ

The results were highly significant and dose-dependent

Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients

These effects are thought to be mediated by the neurotrophic actions of IGF-1, which crosses the blood-brain barrier and activates neuronal survival and synaptic plasticity pathways